JPRN-UMIN000018567尚未招募未知
Rituximab administration for chronic antibody-mediated rejection after kidney transplantation - Rituximab administration for chronic antibody-mediated rejection after kidney transplantation
Department of Nephrology and Hypertension, Saitama Medical Center, Saitama Medical University0 个研究点目标入组 1 人开始时间: 2015年8月14日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 尚未招募
- 发起方
- 入组人数
- 1
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18years-old 至 75years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •The patient who is judged by the patient's physician as unsuitable for participation in the study
研究者
相似试验
进行中（未招募）
1 期
Single-agent rituximab as maintenance treatment versus observation after combined induction immunochemotherapy with fludarabine, cyclophosphamide and rituximab (FCR) in patients older than 65 years with previously untreated B-cell chronic lymphocytic leukemia (B-CLL): a phase III intergroup trial of the GOELAMS and the FCGCLL/WM groups. - LLC 2007 SAEUCTR2007-001015-28-FRCHU TOURS304
已完成
2 期
Rituximab Maintenance Therapy for Marginal Zone B-cell Lymphoma (MZL)LymphomaNCT01213095Dong-A University Hospital48
已完成
不适用
Rituximab treatment of cyclophosphamide-resistant patients with ANCA-associated vasculitisANCA-associated vasculitisJPRN-UMIN000000906Research Comittee of Intractable Vasculitis Syndrome of the Ministry of Health, Labor and Welfare of Japan15
尚未招募
2 期
Cure rate of childhood B cell lymphoma with rituximab and reduced strength of chemotherapyCTRI/2017/09/009650Cancer Institute adyar
进行中（未招募）
不适用
Rituximab-2cda + Rituximab maintenance in Chronic Lymphocytic Leukaemia and Small Lymphocytic Lymphoma - NDEUCTR2010-018519-14-ITISTITUTO EUROPEO DI ONCOLOGIA